3M India (523395) Investor presentation summary
Event summary combining transcript, slides, and related documents.
Investor presentation summary
11 Mar, 2026Global presence and innovation
Over 123 years of innovation with deep material science expertise and iconic brands like Scotch, Post-it, and Command.
Operates at scale with 198 plants and distribution centers, 62,000 employees, and 4,000 tech employees.
Holds approximately 135,000 patents in its history, reflecting a strong focus on R&D.
2025 net sales projected at $24.6B across key sectors: Safety & Industrial, Transportation & Electronics, Healthcare, and Consumer.
Priority verticals include aerospace, automotive, energy, electronics, semiconductors, and home improvement.
India operations and performance
Incorporated in 1987 and publicly listed since 1991, with three manufacturing facilities and one R&D center.
FY 2024-25 sales reached INR 4,446 crores, with 13.6% YTD growth in Q3 FY2025-26.
Employs around 1,255 people in India.
Four business groups: Safety & Industrial (36% mix, 9.1% growth), Transportation & Electronics (32% mix, 14.7% growth), Healthcare (20% mix, 16.1% growth), Consumer (11% mix, 15.5% growth).
Revenue and profit before tax have shown consistent growth, with a 10% CAGR in revenue and 13.4% CAGR in PBT over the last decade.
Strategic growth initiatives
Focus on commercial excellence through stronger pipelines, customer experience, and specification wins.
Local R&D capability emphasized for India-specific products and leveraging global innovations.
Strengthening local supply chain with expanded manufacturing and outsourcing.
Building organizational talent and fostering a culture of aspiration, speed, and performance.
Latest events from 3M India
- Q3 FY26 saw 12.7% sales growth YoY, but a net loss due to exceptional labor and tax charges.523395
Q3 25/2612 Feb 2026 - FY 2024-25 saw 6.1% revenue growth, margin pressure, and a focus on localization and innovation.523395
Status Update13 Nov 2025 - Q2 FY26 delivered 14% sales growth and 43% PAT growth YoY, with broad-based segment gains.523395
Q2 25/263 Nov 2025 - Q1 FY25 profit rose 22% year-over-year on flat revenue, led by Consumer and Safety & Industrial.523395
Q1 24/2525 Aug 2025 - Revenue up 8% YoY, profit and margins down; Health Care leads, cost pressures persist.523395
Q3 24/2525 Aug 2025 - FY25 revenue up 6% with stable EBITDA, but net profit down 18%; Rs. 535/share dividend proposed.523395
Q4 24/2525 Aug 2025 - Sales up 7% YoY, but EBITDA and profit declined amid cost pressures; Health Care led growth.523395
Q2 24/2525 Aug 2025 - Q1 FY26 revenue up 14.3% YoY, PAT up 13.1%, and ₹535/share dividend recommended.523395
Q1 25/2625 Aug 2025